Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease
ST. LOUIS, Mo. & CONCORD, Mass.--(BUSINESS WIRE)--Dec 5, 2023--
Source: eagletribune.com
Geneoscopy Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Geneoscopy Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Geneoscopy Inc Today - Breaking & Trending Today
Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Op
Adiso to Utilize Noninvasive RNA Technology Developed by Geneoscopy as a Precision Immunology Measure in ADS051 Phase 2 IBD TrialST. LOUIS, Mo. & CONCORD, Mass.--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing noninvasive diagnostic and precision medicine tools for gastrointestinal h...
Source: pharmiweb.com
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that it has filed a lawsuit...
Source: prnewswire.com
Geneoscopy to Present and Exhibit at American College of Gastroenterology 2023 Annual Meeting
ST. LOUIS, October 05, 2023--Geneoscopy will showcase its noninvasive RNA-based technology platform designed to improve diagnostic tools for gastrointestinal health.
Source: yahoo.com
Second Most Fatal Cancer in U.S. May Soon Face A Challenger: Mainz Biomed's (NASDAQ: MYNZ) Early Detection Tech - Exact Sciences (NASDAQ:EXAS), Mainz Biomed (NASDAQ:MYNZ)
Colorectal cancer is the third most common cancer worldwide, and although the majority of colorectal cancer cases have historically occurred in individuals aged 45 and older, it is increasingly affecting younger people.
Source: benzinga.com